Zofran Lawsuit News Update: Ohio Zofran Lawsuit Alleges Wrongful Death
St. Louis, MO (PRWEB) June 23, 2015 -- Attorneys handling national Zofran lawsuits announce a Zofran lawsuit news update now available at their website, the Zofran Birth Defects Lawsuit Center. The new article* concerns a Zofran lawsuit that was filed in Ohio by parents of a child who died just three days after her birth, according to court documents.** The child died as a result of birth defects, which the lawsuit allege were caused by prenatal exposure to Zofran, according to court documents.
The child in question was exposed to Zofran when her mother was prescribed the drug to treat morning sickness by her doctor, according to court documents. The complaint alleges the Zofran was presented as a safe medication for the treatment of nausea during pregnancy by the drug company, GlaxoSmithKline. Mirroring other Zofran lawsuits, this claim alleges that GSK illegally promoted Zofran to pregnant women, which is considered an off-label use do to the fact that Zofran has not been approved for use in pregnant women by the FDA, according to court documents.
The child in question was born on March 17, 2006 and immediately diagnosed with a right ventrical heart defect, according to the court documents. She was cared for in the ICU until she died on March 20, 2006 at the age of three days old, according to court documents.
The Zofran lawsuit alleges that GSK knew or should have known of risks to pregnant mothers and fetuses posed by Zofran use during pregnancy, yet failed to adequately warn consumers. Furthermore, the plaintiffs allege GSK knowingly promoted the drug for a variety of off-label conditions, the subject of a 2012 settlement with the U.S. Department of Justice for $3 billion, according to court documents.
Furthermore, this Zofran lawsuit alleges that GSK has concealed information regarding the risks associated with Zofran and the injuries it has caused, according to court documents. The plaintiffs, who are the child’s parents, allege that Zofran and GSK are responsible for the wrongful death of their child, according to court documents.
Attorneys handling national Zofran lawsuits for the Onder Law Firm are currently offering no-cost, no-obligation Zofran lawsuit case review for parents and families whose child was born with birth defects and was possibly exposed to Zofran during prenatal development. These Zofran attorneys believe persons who meet this description may be entitled to compensation through filing a Zofran lawsuit. Nationally-renowned for groundbreaking work in drug and product safety litigation against multi-billion dollar corporations, the Onder Law Firm’s Zofran lawyers have committed their significant resources to providing expert legal representation to women, children and families who believe they may have grounds to file Zofran lawsuits. The firm provides regular Zofran lawsuit news updates at their website in order to inform the public of current pending litigation on the subject.
The Onder Law Firm welcomes Zofran lawsuit case inquiries from law firms in regards to handling them or working as co-counsel.
About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The pharmaceutical and medical device litigators at The Onder Law Firm have represented thousands of Americans in lawsuits against multinational conglomerates from products liability for manufacture of defective or dangerous products to deceptive advertising practices. Other firms throughout the nation often seek its experience and expertise on complex litigation. It is also a recognized leader in products liability cases such as window blind cord strangulation. The Onder Law Firm offers information from attorneys handling talcum powder lawsuits at http://www.ZofranBirthDefectsLawsuitCenter.com.
*zofranbirthdefectslawsuitcenter.com/news/new-zofran-lawsuit-in-ohio-claims-drug-caused.asp
**US District Court, Northern District of Ohio, Case No. 3:15-cv-1166, filed 6/10/15
Michael Gudeman, Gudeman Group, +1 314-614-8709, [email protected]
Share this article